1. Home
  2. EXR vs IQV Comparison

EXR vs IQV Comparison

Compare EXR & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Extra Space Storage Inc

EXR

Extra Space Storage Inc

HOLD

Current Price

$140.06

Market Cap

30.3B

Sector

Real Estate

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$260.31

Market Cap

35.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXR
IQV
Founded
1977
1982
Country
United States
United States
Employees
N/A
93000
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3B
35.1B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
EXR
IQV
Price
$140.06
$260.31
Analyst Decision
Buy
Strong Buy
Analyst Count
15
16
Target Price
$144.80
$227.13
AVG Volume (30 Days)
761.6K
1.2M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
4.61%
N/A
EPS Growth
13.90
4.67
EPS
2.39
1.61
Revenue
$3,377,542,000.00
$9,739,000,000.00
Revenue This Year
N/A
$6.77
Revenue Next Year
$3.63
$5.89
P/E Ratio
$58.23
$161.00
Revenue Growth
3.70
41.60
52 Week Low
$125.71
$154.50
52 Week High
$158.88
$271.80

Technical Indicators

Market Signals
Indicator
EXR
IQV
Relative Strength Index (RSI) 33.65 62.56
Support Level $139.88 $218.57
Resistance Level $146.69 N/A
Average True Range (ATR) 2.30 7.38
MACD -0.61 -0.78
Stochastic Oscillator 16.60 67.41

Price Performance

Historical Comparison
EXR
IQV

About EXR Extra Space Storage Inc

Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages more than 4,200 self-storage properties in 43 states, with over 330 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: